Sure. Earn more money now. You

6
Comment
Favorite

giveandtake
2022-03-14

Sure. Earn more money now. You won't get any more chance soon.

Fully Vaccinated Will Need Fourth Dose Later This Year, and New Variant Dubbed 'Deltacron' Detected in Europe

Fully vaccinated people will need a fourth shot later in 2022, according to the head of Pfizer Inc.,

Fully Vaccinated Will Need Fourth Dose Later This Year, and New Variant Dubbed 'Deltacron' Detected in Europe

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

Top
Latest

No comments yet

Most Discussed

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":9032304211,"tweetId":"9032304211","gmtCreate":1647271599444,"gmtModify":1676534210680,"author":{"id":3582239313452026,"idStr":"3582239313452026","authorId":3582239313452026,"authorIdStr":"3582239313452026","name":"giveandtake","avatar":"https://static.itradeup.com/news/7412c0630d30fa9af024d2d293f9615c","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":1,"individualDisplayBadges":[],"fanSize":6,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Sure. Earn more money now. You won't get any more chance soon.</p></body></html>","htmlText":"<html><head></head><body><p>Sure. Earn more money now. You won't get any more chance soon.</p></body></html>","text":"Sure. Earn more money now. You won't get any more chance soon.","highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/9032304211","repostId":2219272748,"repostType":4,"repost":{"id":"2219272748","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1647270900,"share":"https://ttm.financial/m/news/2219272748?lang=en_US&edition=fundamental","pubTime":"2022-03-14 23:15","market":"us","language":"en","title":"Fully Vaccinated Will Need Fourth Dose Later This Year, and New Variant Dubbed 'Deltacron' Detected in Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2219272748","media":"Dow Jones","summary":"Fully vaccinated people will need a fourth shot later in 2022, according to the head of Pfizer Inc.,","content":"<html><head></head><body><p>Fully vaccinated people will need a fourth shot later in 2022, according to the head of Pfizer Inc., who said that COVID-19 is not going to just go away in the coming years.</p><p>Albert Bourla told CBS News reporter Margaret Brennan on &#34;Face the Nation&#34; that people are going to have to learn to live with the virus.</p><p>He said a fourth dose -- a second booster -- is necessary &#34;right now.&#34;</p><p>&#34;The protection that you are getting from the third, it is good enough, actually quite good for hospitalizations and deaths,&#34; he said, according to a CBS News transcript. &#34;It&#39;s not that good against infections, but doesn&#39;t last very long.&#34;</p><p>A second booster has already been approved for some immunocompromised people.</p><p>Bourla said he expects the COVID booster to become an annual occurrence, much like the flu shot, and added that Pfizer is working on a vaccine that offers even better protection.</p><p>Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> is currently working to make a vaccine that will protect against all variants, including omicron, &#34;but also something that can protect for at least a year. And if we be able to achieve that, then I think it is very easy to follow and remember so that we can go back to really the way used to live,&#34; he said.</p><p>Bourla is expecting data from trials of the vaccine in children below the age of 5 to be ready in April. If those prove successful and are authorized, the first shots in that age group could come in May.</p><p>U.S. COVID numbers continue to decline, and the nation is now averaging 34,232 new cases a day, according to a New York Times tracker, down 48% from two weeks ago.</p><p>The average daily number of hospitalizations stands at 29,688, down 42% from two weeks ago. Deaths are averaging 1,291 a day, down 31% from two weeks ago, but still an undesirably high number.</p><p>A new COVID variant, that is being called deltacron for now as it combines elements of the delta and omicron variants, has been detected in several European countries, but it&#39;s too early to say whether it&#39;s more transmissible or more lethal than other ones.</p><p>The World Health Organization confirmed the variant has been found in small numbers in France, the Netherlands and Denmark, as WebMD reported</p><p>&#34;We have not seen any change in the epidemiology with this recombinant. We haven&#39;t seen any change in severity. But there are many studies that are under way,&#34; World Health Organization COVID-19 technical lead Maria Van Kerkhove, Ph.D., said at a news conference.</p><p>The new variant is expected to spread, however, she added, cautioning that again, &#34;the pandemic is far from over.&#34;</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fully Vaccinated Will Need Fourth Dose Later This Year, and New Variant Dubbed 'Deltacron' Detected in Europe</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFully Vaccinated Will Need Fourth Dose Later This Year, and New Variant Dubbed 'Deltacron' Detected in Europe\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2022-03-14 23:15</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Fully vaccinated people will need a fourth shot later in 2022, according to the head of Pfizer Inc., who said that COVID-19 is not going to just go away in the coming years.</p><p>Albert Bourla told CBS News reporter Margaret Brennan on &#34;Face the Nation&#34; that people are going to have to learn to live with the virus.</p><p>He said a fourth dose -- a second booster -- is necessary &#34;right now.&#34;</p><p>&#34;The protection that you are getting from the third, it is good enough, actually quite good for hospitalizations and deaths,&#34; he said, according to a CBS News transcript. &#34;It&#39;s not that good against infections, but doesn&#39;t last very long.&#34;</p><p>A second booster has already been approved for some immunocompromised people.</p><p>Bourla said he expects the COVID booster to become an annual occurrence, much like the flu shot, and added that Pfizer is working on a vaccine that offers even better protection.</p><p>Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> is currently working to make a vaccine that will protect against all variants, including omicron, &#34;but also something that can protect for at least a year. And if we be able to achieve that, then I think it is very easy to follow and remember so that we can go back to really the way used to live,&#34; he said.</p><p>Bourla is expecting data from trials of the vaccine in children below the age of 5 to be ready in April. If those prove successful and are authorized, the first shots in that age group could come in May.</p><p>U.S. COVID numbers continue to decline, and the nation is now averaging 34,232 new cases a day, according to a New York Times tracker, down 48% from two weeks ago.</p><p>The average daily number of hospitalizations stands at 29,688, down 42% from two weeks ago. Deaths are averaging 1,291 a day, down 31% from two weeks ago, but still an undesirably high number.</p><p>A new COVID variant, that is being called deltacron for now as it combines elements of the delta and omicron variants, has been detected in several European countries, but it&#39;s too early to say whether it&#39;s more transmissible or more lethal than other ones.</p><p>The World Health Organization confirmed the variant has been found in small numbers in France, the Netherlands and Denmark, as WebMD reported</p><p>&#34;We have not seen any change in the epidemiology with this recombinant. We haven&#39;t seen any change in severity. But there are many studies that are under way,&#34; World Health Organization COVID-19 technical lead Maria Van Kerkhove, Ph.D., said at a news conference.</p><p>The new variant is expected to spread, however, she added, cautioning that again, &#34;the pandemic is far from over.&#34;</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4139":"生物科技","BK4576":"AR","BK4533":"AQR资本管理(全球第二大对冲基金)","PFE":"辉瑞","BK4566":"资本集团","BK4575":"芯片概念","BK4505":"高瓴资本持仓","BK4535":"淡马锡持仓","BK4515":"5G概念","BK4559":"巴菲特持仓","BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4579":"人工智能","BK4548":"巴美列捷福持仓","BK4507":"流媒体概念","BNTX":"BioNTech SE","BK4170":"电脑硬件、储存设备及电脑周边","BK4551":"寇图资本持仓","BK4007":"制药","BK4574":"无人驾驶","BK4573":"虚拟现实","BK4554":"元宇宙及AR概念","BK4532":"文艺复兴科技持仓","BK4581":"高盛持仓","BK4527":"明星科技股","BK4512":"苹果概念","BK4501":"段永平概念","BK4553":"喜马拉雅资本持仓","BK4571":"数字音乐概念"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2219272748","content_text":"Fully vaccinated people will need a fourth shot later in 2022, according to the head of Pfizer Inc., who said that COVID-19 is not going to just go away in the coming years.Albert Bourla told CBS News reporter Margaret Brennan on \"Face the Nation\" that people are going to have to learn to live with the virus.He said a fourth dose -- a second booster -- is necessary \"right now.\"\"The protection that you are getting from the third, it is good enough, actually quite good for hospitalizations and deaths,\" he said, according to a CBS News transcript. \"It's not that good against infections, but doesn't last very long.\"A second booster has already been approved for some immunocompromised people.Bourla said he expects the COVID booster to become an annual occurrence, much like the flu shot, and added that Pfizer is working on a vaccine that offers even better protection.Pfizer $(PFE)$ is currently working to make a vaccine that will protect against all variants, including omicron, \"but also something that can protect for at least a year. And if we be able to achieve that, then I think it is very easy to follow and remember so that we can go back to really the way used to live,\" he said.Bourla is expecting data from trials of the vaccine in children below the age of 5 to be ready in April. If those prove successful and are authorized, the first shots in that age group could come in May.U.S. COVID numbers continue to decline, and the nation is now averaging 34,232 new cases a day, according to a New York Times tracker, down 48% from two weeks ago.The average daily number of hospitalizations stands at 29,688, down 42% from two weeks ago. Deaths are averaging 1,291 a day, down 31% from two weeks ago, but still an undesirably high number.A new COVID variant, that is being called deltacron for now as it combines elements of the delta and omicron variants, has been detected in several European countries, but it's too early to say whether it's more transmissible or more lethal than other ones.The World Health Organization confirmed the variant has been found in small numbers in France, the Netherlands and Denmark, as WebMD reported\"We have not seen any change in the epidemiology with this recombinant. We haven't seen any change in severity. But there are many studies that are under way,\" World Health Organization COVID-19 technical lead Maria Van Kerkhove, Ph.D., said at a news conference.The new variant is expected to spread, however, she added, cautioning that again, \"the pandemic is far from over.\"","news_type":1,"symbols_score_info":{"BNTX":0.9,"END":1,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":2618,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":51,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}